Skip to content

Preliminary clinical study of autologous platelet rich plasma used in endometrial repair after hysterscopic adhesiolysis

Preliminary clinical study of autologous platelet rich plasma used in endometrial repair after hysterscopic adhesiolysis

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018703
Enrollment
Unknown
Registered
2018-10-04
Start date
2018-10-08
Completion date
Unknown
Last updated
2018-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intrauterine adhension

Interventions

Sponsors

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Women of childbearing aged 18 to 40 years old; 2) with regular menstruation and history of pregnancy; 3) patients with oligomenorrhea or secondary amenorrhea who were undergoing hysterscopic adhesiolysis for moderate and severe uterine adhesion.

Exclusion criteria

Exclusion criteria: 1) Previous operation history for intrauterine adhesion; 2) patients who have a previous history of uterine tuberculosis or are currently on drug treatment for tuberculosis; 3) patients with uncertain nature of endometrial lesions (such as endometrial dysplasia and carcinogenesis); 4) acute genital tract infection; 5) genital tract malformation; 6) severe hepatic and renal insufficiency: ALT>80U/L, Cr.>100 mol/L; 7) patients with a history of thrombosis or risk factors for thrombosis, such as APS (+), are not suitable for patients with high dose of estrogen; 8) platelet <80 x 10^9/L.

Design outcomes

Primary

MeasureTime frame
menstrual quantity;thickness of endometrium around ovulational peried;intrauterine morphology;PDGF;TGF-ß;IGF;EGF;VEGF;

Secondary

MeasureTime frame
Colour and lustre of endometrium;

Countries

China

Contacts

Public ContactShan Deng

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences,

pumchdengshan@163.com13671217795

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026